Cloud-based bioreactor lab for remote bioprocess development
Culture Biosciences operates a remote bioreactor service where scientists design experiments and Culture executes them using 250mL bioreactors, with real-time monitoring via cloud dashboard. The tech stack—Python, AWS, GCP, Azure, embedded systems (Raspberry Pi), plus CAD tools (Onshape, Solidworks, NX)—reflects a hardware-cloud hybrid business: on-premises bioreactor control paired with cloud data acquisition and analysis. Hiring is acceleration-phase and intern-heavy (4 of 6 roles), concentrated in engineering and product, suggesting active platform development rather than sales scaling.
Culture Biosciences offers a managed bioreactor service targeting biotech R&D teams. Instead of building and maintaining in-house bioreactors, customers submit experiment designs to Culture's South San Francisco lab, where the company executes batch runs on 250mL bioreactors and streams live data back via web dashboard. The business removes the operational burden of high-throughput bioprocess execution, letting scientists focus on hypothesis iteration and decision-making. Current project work spans embedded system drivers, cloud platform development, and bioprocessing tooling—indicating investment in both hardware reliability and analytical software depth.
Culture operates a cloud-connected bioreactor service. Scientists submit experiment designs; Culture executes them in 250mL bioreactors at their South San Francisco lab and delivers real-time data via online dashboard.
Python, AWS, GCP, Azure for cloud services; Raspberry Pi for embedded bioreactor control; Onshape and Solidworks for hardware CAD; Jira and Linear for project management; HubSpot for sales.
Other companies in the same industry, closest in size